A detailed history of Financial Advisory Group transactions in Johnson & Johnson stock. As of the latest transaction made, Financial Advisory Group holds 4,493 shares of JNJ stock, worth $740,536. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,493
Previous 4,493 -0.0%
Holding current value
$740,536
Previous $704,000 0.85%
% of portfolio
0.13%
Previous 0.14%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $4,513 - $4,925
31 Added 0.69%
4,493 $704,000
Q3 2023

Dec 07, 2023

SELL
$155.75 - $174.48 $38,003 - $42,573
-244 Reduced 5.18%
4,462 $694,000
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $11,630 - $13,880
-77 Reduced 1.61%
4,706 $729,000
Q4 2022

Feb 09, 2023

SELL
$160.2 - $179.79 $77,376 - $86,838
-483 Reduced 9.17%
4,783 $845,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $5,646 - $6,283
35 Added 0.67%
5,266 $860,000
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $66,771 - $73,845
-397 Reduced 7.05%
5,231 $929,000
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $32,260 - $36,636
204 Added 3.76%
5,628 $997,000
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $311 - $346
2 Added 0.04%
5,424 $928,000
Q3 2021

Nov 09, 2021

BUY
$161.5 - $179.47 $2,907 - $3,230
18 Added 0.33%
5,422 $876,000
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $44,335 - $47,557
-278 Reduced 4.89%
5,404 $890,000
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $48,676 - $54,212
-318 Reduced 5.3%
5,682 $934,000
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $43,600 - $50,046
318 Added 5.6%
6,000 $944,000
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $82,824 - $90,759
-590 Reduced 9.41%
5,682 $846,000
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $17,782 - $24,638
160 Added 2.62%
6,272 $822,000
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $11,672 - $12,837
89 Added 1.48%
6,112 $806,000
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $125 - $139
1 Added 0.02%
6,023 $842,000
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $12,161 - $14,636
-99 Reduced 1.62%
6,022 $777,000
Q3 2018

Oct 09, 2018

BUY
$121.58 - $142.88 $12,279 - $14,430
101 Added 1.68%
6,121 $846,000
Q2 2018

Aug 08, 2018

BUY
$119.4 - $131.76 $5,253 - $5,797
44 Added 0.74%
6,020 $730,000
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $125 - $148
1 Added 0.02%
5,976 $766,000
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $131 - $143
1 Added 0.02%
5,975 $835,000
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $773,453 - $808,760
5,974
5,974 $777,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Financial Advisory Group Portfolio

Follow Financial Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Group with notifications on news.